首页> 外国专利> Benzimidazole derivatives (optionally with saccharide substituents) useful for the treatment or prophylaxis of viral infections (particularly herpes, cytomegalovirus and Hepatitis B) or for the treatment or prophylaxis of restenosis

Benzimidazole derivatives (optionally with saccharide substituents) useful for the treatment or prophylaxis of viral infections (particularly herpes, cytomegalovirus and Hepatitis B) or for the treatment or prophylaxis of restenosis

机译:苯并咪唑衍生物(可选具有糖取代基)可用于治疗或预防病毒感染(尤其是疱疹,巨细胞病毒和乙型肝炎)或用于治疗或预防再狭窄

摘要

The benzimidazole derivative of formula (I) or salt or pharmaceutical composition thereof, where in the formula (I): R1 is halogen, hydroxy, azido, alkyl, alkoxy, alkenyl, alkynyl, arylalkenyl, arylalkynyl, or -NR19R20 (where R19 and R20 may be the same or different and are H, alkyl, cyanoalkyl, hydroxyalkyl, haloalkyl, cycloalkyl, alkylcycloalkyl, alkenyl, cycloalkylalkyl, alkynyl, aryl, arylalkyl, heterocyclealkyl, alkylcarbonyl, arylsulfonyl, or R19R20 together with the N atom to which they are attached from a 3, 4, 5 or 6 membered heterocyclic ring), OR21 (where R21 is H, alkyl, cycloalkyl, or aryl), or SR22 (where R22 is H, alkyl, hydroxyalkyl, cycloalkyl, or aryl). R2 is H or halogen. R3 and R4 may be the same or different and are H, halogen, alkyl, aryl, heterocyclearyl, alkoxy, haloalkyl or -SR24 (where R24 is H, alkyl, aryl, or arylalkyl). Z is a substituent of formula (la) or (Ib), wherein: R5 is H, alkyl, haloalkyl or alkoxy. R6 is H, hydroxy, halogen, alkyl, hydroxyalkyl, haloalkyl or alkoxy. R7 is H, hydroxy, halogen, alkyl, hydroxyalkyl, haloalkyl, alkoxy, or R6 and R7 together form a ketone or alkene. R8 - R11 may be the same or different and are H, hydroxy, halogen, alkyl, hydroxyalkyl, haloalkyl, alkoxy, or any of R8 and R9 or R10 and R11 together form a ketone or alkene. R12 - R14 may be the same or different and are H, hydroxy, alkyl or hydroxyalkyl. With the following provisos: i) The compound of formula (I) cannot be 2,5-dimethyl-1-(2,3,4-tri-O-acetyl-beta-D-xylopyranosyl)-1 H-benzimidazole or 5,6-dimethyl-1-(2,3,4-tri-O-acetyl-beta-D-arabinopyranosyl)-benzimidazole-2-thione. ii) When Z is a substituent of formula (la) R2, R3, and R4 cannot all be H. iii) When Z is a substituent of formula (la) or (Ib) R1 cannot be NR19R20 where R19 and R20 together with the N atom to which they are attached form a 5 membered heterocyclic ring containing S. The compound or salt of formula (I) is used for the treatment or prophylaxis of a viral infection (especially herpes, cytomegalovirus and Hepatitis B) or for the treatment or prophylaxis of restenosis.
机译:式(I)的苯并咪唑衍生物或其盐或药物组合物,其中式(I)中:R1为卤素,羟基,叠氮基,烷基,烷氧基,烯基,炔基,芳基烯基,芳基炔基或-NR19R20(其中R19和R 20可以相同或不同,并且是H,烷基,氰基烷基,羟烷基,卤代烷基,环烷基,烷基环烷基,烯基,环烷基烷基,炔基,芳基,芳基烷基,杂环烷基,烷基羰基,芳基磺酰基或R19R20以及它们所属于的N原子由3、4、5或6元杂环连接),OR21(其中R21为H,烷基,环烷基或芳基)或SR22(其中R22为H,烷基,羟烷基,环烷基或芳基)。 R 2是H或卤素。 R 3和R 4可以相同或不同,并且为H,卤素,烷基,芳基,杂环芳基,烷氧基,卤代烷基或-SR 24(其中R 24为H,烷基,芳基或芳基烷基)。 Z为式(Ia)或(Ib)的取代基,其中:R 5为H,烷基,卤代烷基或烷氧基。 R 6是H,羟基,卤素,烷基,羟烷基,卤代烷基或烷氧基。 R 7是H,羟基,卤素,烷基,羟烷基,卤代烷基,烷氧基,或R 6和R 7一起形成酮或烯烃。 R 8 -R 11可以相同或不同,并且是H,羟基,卤素,烷基,羟烷基,卤代烷基,烷氧基,或R 8和R 9或R 10和R 11中的任何一个一起形成酮或烯烃。 R 12 -R 14可以相同或不同,并且为H,羟基,烷基或羟烷基。具有以下条件:i)式(I)的化合物不能为2,5-二甲基-1-(2,3,4-三-O-乙酰基-β-D-吡喃吡喃糖基)-1 H-苯并咪唑或5 ,6-二甲基-1-(2,3,4-三-O-乙酰基-β-D-阿拉伯吡喃糖基)-苯并咪唑-2-硫酮。 ii)当Z是式(Ia)的取代基时,R2,R3和R4不能全部为H。iii)当Z是式(Ia)或(Ib)的取代基时,R1不能为NR19R20,其中R19和R20与与它们相连的N原子形成一个含S的5元杂环。式(I)化合物或盐用于治疗或预防病毒感染(尤其是疱疹,巨细胞病毒和乙型肝炎)或用于治疗或预防再狭窄。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号